This final chapter attempts to search for reasons to explain why so little progress has been made in the practical clinical application of aptamers and propose potential solutions to the problem. The advantages and limitations of aptamers in clinical settings are first carefully evaluated. It is suggested that in order to increase the clinical application of aptamers, new selection methods are needed to further improve the success rate of aptamer selection and to efficiently generate stable aptamers for in vivo application with low cost. Several new and promising aptamer selection methods are then reviewed. Strategies for improving selection success rate are highlighted. Finally, efforts leading to the selection of stable aptamers and, hence, increasing the potential for the practical use of aptamer-based technology in clinical settings, are discussed.Keywords Aptamer Á Base modification Á Spiegelmer Á Microfluidics Á SELEX
IntroductionBased on their unique functions and features, as discussed throughout the chapters of this book, aptamers have been developed over the past 25 years for applications in chemical sensing, clinical diagnosis, targeted drug delivery, and therapy [1][2][3][4][5][6]. Moreover, the utility of aptamers has been amplified by their compatibility with such detection schemes as electrochemistry [7], fluorescence [8,9], colorimetrics [6,[10][11][12], chemiluminescence [13], field effect transistors [14], and surface plasmon resonance (SPR) [15,16]. However, while aptamer development has flourished in the laboratory, the commercialization of aptamers, especially for biomedical applications, has lagged far behind. Since the invention of aptamer